Trend Results : Memorial Sloan Kettering


Blog Post Results (1-20 of 134)

FILTER RESULTS

Memorial Sloan Kettering, Cota Partner to Advance Personalized Cancer Treatment

In 2011, Cota, a healthcare data and analytics company bridging precision medicine and population health, was founded by doctors for doctors. Over the past six years, the start-up has moved beyond precision medicine as a goal to a reality, and just this past year, have secured a multi-year collaboration with Novartis towards breast cancer and recruited... Read More

Young Investigators Named Winners of 2017 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year's Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in advancing cancer research.

New Study Findings Unlock the Secret of Why Some People with Pancreatic Cancer Live Longer than Others

The pancreatic cancer and immunotherapy experts at Memorial Sloan Kettering Cancer Center (MSK) have shown for the first time why some people with pancreatic cancer live many more years than others with the deadly disease.

Targeted Radiotherapy Combined with Immunotherapy Kills 100% of Colorectal Cancer

Researchers from Memorial Sloan Kettering Cancer Center and from MIT are reporting the development of a new combination therapy that completely eliminates colon cancer, at least in laboratory mice. The technique is a type of radioimmunotherapy, which delivers radioactive particles directly to tumors on the backs of targeting antibodies that seek out those tumors. In their […]

Is physician shadowing immoral?

Countless times as a patient both at Memorial Sloan Kettering and Weill Cornell in New York City, I have witnessed doctors arrogantly waltzing into an examination room and arriving not alone but with an entourage. Like Greeks bearing gifts, they arrived with something unwanted and threatening: medical students, interns, residents, and fellows. And not once, […]

New system for treating colorectal cancer can lead to complete cure

(Society of Nuclear Medicine and Molecular Imaging) Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. Show More Summary

Khloe Kardashian Grants Young Cancer Patient Her Big Wish!

Khloe Kardashian made a young fan’s dream come true when she showed up to the girl’s room at Memorial Sloan Kettering Cancer Center in Los Angeles. The 33-year-old pregnant reality star took time out of her busy schedule to meet with a 10-year-old girl named Hailey Cordova. Hailey‘s mom tweeted out a photo of the [...]

Norwalk Hospital and Memorial Sloan Kettering Launch Unique Cancer Care Collaboration

Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital, a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing cancer program at Norwalk Hospital.

Cancer Immunologist Andrea Schietinger of Sloan Kettering Institute Honored with Prestigious NIH Director's New Innovator Award

Cancer immunologist Andrea Schietinger, PhD, of the Sloan Kettering Institute (SKI) at Memorial Sloan Kettering (MSK) has been honored with the prestigious National Institutes of Health (NIH) Director's New Innovator Award.

m6A Enzymes Found to Be Central to the Development of AML

A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could provide a rationale for targeting the RNA methylation program in myeloid leukemia.

GIST Tumors Linked to NF1 Mutations, Genetic Testing Needed

Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.

GIST tumors linked to NF1 mutations, genetic testing needed

(University of California - San Diego) Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bowel, called the duodenal-jejunal flexure or DJF, shows a high frequency of gastrointestinal stromal tumors (GISTs) with mutations of the NF1 gene.

Going nano in the fight against cancer

Imagine being able to see the signs of cancer decades before we can now. URI Chemical Engineering Assistant Professor Daniel Roxbury and researchers from Memorial Sloan Kettering Cancer Center have invented a technique that could detect a wide range of biomarkers that signal the start of cancer—many years before symptoms surface.

Knee joint signals bones to grow

(eLife ) Scientists from the Memorial Sloan Kettering Cancer Center, US, have revealed a communication system between the knee joint and developing bones in mice, which controls bone growth during early development and after injury.

Gut bacteria could protect cancer patients and pregnant women from Listeria, study suggests

(Rockefeller University Press) Researchers at Memorial Sloan Kettering Cancer Center in New York have discovered that bacteria living in the gut provide a first line of defense against severe Listeria infections. The study, which will...Show More Summary

Trends in reoperation after initial lumpectomy for breast cancer

(The JAMA Network Journals) Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative margin for invasive breast cancer on postlumpectomy surgery and final surgical treatment.

Real-Time, Patient-Reported Symptom Monitoring Demonstrates an Overall Survival Benefit

Updated results of a clinical trial that launched in 2007 were presented today by Ethan Basch, MD, of Memorial Sloan Kettering Cancer Center (MSK) and UNC Lineberger Comprehensive Cancer Center, at the annual meeting of the American Society of Clinical Oncology. Show More Summary

Philips in deals with U.S. hospitals on use of its gene data platform for cancer research

6 months agoHealth : Reuters: Health

AMSTERDAM (Reuters) - Dutch healthcare technology company Philips said Thursday it had reached deals with New York's Memorial Sloan Kettering Cancer Center (MSK) and Utah-based Intermountain Healthcare for them to use its genomics platform for cancer research and treatment.

Landmark Analysis From Memorial Sloan Kettering Reveals Genomic Tumor Sequence of More Than 10,000 Cancer Patients Using MSK-IMPACT(tm)

Memorial Sloan Kettering (MSK) has reached a major milestone in bringing personalized treatments to more cancer patients. Michael Berger, PhD, Ahmet Zehir, PhD, and colleagues have reported an in-depth analysis of the first 10,336 patients...Show More Summary

World-Renowned Medical Oncologist Luis Diaz, MD, Named Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center

Luis A. Diaz, MD, has been named the Head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering (MSK). An accomplished physician, pioneering researcher, and leader in the field of clinical oncology, Dr. Diaz most recently served as an associate professor of oncology at the Johns Hopkins University School of Medicine.

Copyright © 2015 Regator, LLC